Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Exametazime

CompanyAnazaoHealth Corporation (DUNS: 011038762)

Effective Date

July 1, 2012

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Exametazime(1 mg in 1 1)

Manufacturing Establishments (1)

AnazaoHealth Corporation

Labeler

AnazaoHealth Corporation

DUNS Number

011038762

Products (1)

Exametazime HMPAO

NDC Product Code

51808-214

Route of Administration

INTRAVENOUS

Effective Date

November 28, 2012

Ingredients

ExametazimeActive

Code: G29272NCKLClass: ACTIBQuantity: 1 mg in 1 1

SODIUM CHLORIDEInactive

Code: 451W47IQ8XClass: IACTQuantity: 6.75 mg in 1 1

STANNOUS CHLORIDEInactive

Code: 1BQV3749L5Class: IACTQuantity: 11.4 ug in 1 1

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy